Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

244.16
-3.0000-1.21%
Volume:108.85K
Turnover:26.57M
Market Cap:6.84B
PE:-3.74
High:246.82
Open:246.82
Low:242.52
Close:247.16
Loading ...

Binance Labs Enters DeSci Space with BIO Protocol Investment

BE[IN]CRYPTO
·
09 Nov 2024

KALA BIO Inc expected to post a loss of $2.43 a share - Earnings Preview

Reuters
·
09 Nov 2024

SAB BIO Q3 2024 Cash, Cash Equivalents Available $30.4M-$56.6M

Benzinga
·
07 Nov 2024

Interpreting Bio-Rad (BIO) International Revenue Trends

Zacks
·
04 Nov 2024

Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.
·
02 Nov 2024

Tiziana Life Sciences Highlights Advancements at BIO-Europe 2024

TIPRANKS
·
02 Nov 2024

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

GlobeNewswire
·
02 Nov 2024

Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)

Simply Wall St.
·
01 Nov 2024

Bio-Rad Labs misses Q3 estimates for profit, revenue

seekingalpha
·
01 Nov 2024

Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital

Dow Jones
·
01 Nov 2024

Q3 2024 Bio Rad Laboratories Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Nov 2024

UBS Adjusts Price Target on Bio-Rad Laboratories to $390 From $400, Maintains Buy Rating

MT Newswires Live
·
31 Oct 2024

Stock Track | Bio-Rad Laboratories Soars on Strong Q3 Earnings and Positive Outlook

Stock Track
·
31 Oct 2024

Stock Track | Bio-Rad Laboratories Surges 7.73% on Strong Q3 Earnings and Positive Outlook

Stock Track
·
31 Oct 2024

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Business Wire
·
31 Oct 2024

BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Zacks
·
31 Oct 2024